Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3462
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05049161 A Long-term Extension of Study GNC-401 |
Temelimab 18 mg/kg | SEP | Phase 2 | TERMINATED | En attente / non publié | GeNeuro Innovation SAS | Sweden · Center for Neurology, Academic Specialist Ce… | 2021-08-27 → 2022-05-18 | Ouvrir |
| NCT01639300 Safety Study of GNbAC1 in Multiple Sclerosis Patients |
GNbAC1 | SEP | Phase 2 | COMPLETED | En attente / non publié | GeNeuro Innovation SAS | Switzerland · Hopitaux Universitaires de Genève - HUG… | 2012-07 → 2014-04 | Ouvrir |
| NCT04410991 Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine … |
Tolebrutinib | SEP | Phase 3 | COMPLETED | En attente / non publié | Sanofi | United States, Argentina, Belgium, Brazil, Canada, Ch… | 2020-06-11 → 2024-07-16 | Ouvrir |
| NCT03996291 Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Part… |
Tolebrutinib | SEP | Phase 2 | COMPLETED | En attente / non publié | Sanofi | United States, Canada, Czechia, Estonia, France, Neth… | 2019-09-23 → 2024-11-26 | Ouvrir |
| NCT04742400 Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for… |
tolebrutinib 60mg | SEP | Phase 2 | UNKNOWN | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2021-04-15 → 2025-12-31 | Ouvrir |
| NCT06106074 Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR4421… |
Tolebrutinib | SEP | Phase 1 | COMPLETED | En attente / non publié | Sanofi | United States · New Orleans Clinical Research Site Nu… | 2020-08-10 → 2022-05-23 | Ouvrir |
| NCT04411641 Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of… |
Tolebrutinib | SEP | Phase 3 | COMPLETED | En attente / non publié | Sanofi | United States, Argentina, Australia, Austria, Belarus… | 2020-09-24 → 2024-08-29 | Ouvrir |
| NCT06292923 A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple… |
Foralumab | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Tiziana Life Sciences LTD | United States · Brigham and Women's Hospital, Boston,… | 2023-11-15 → 2026-10 | Ouvrir |
| NCT05029609 Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Seco… |
Intranasal Foralumab Solution | SEP | Phase 1 | WITHDRAWN | En attente / non publié | Tiziana Life Sciences LTD | Non communiqué | 2021-10 → 2022-12 | Ouvrir |
| NCT06802328 Intermediate-Size Patient Population Expanded Access: Foralumab in Non-… |
Foralumab TZLS-401 50 µg | SEP | À vérifier | AVAILABLE | En attente / non publié | Tiziana Life Sciences LTD | United States · Brigham and Women's Hospital, Boston,… | Non communiqué | Ouvrir |
| NCT04414345 HEALEY ALS Platform Trial - Regimen C CNM-Au8 |
CNM-Au8 | SEP | Phase 2 | COMPLETED | En attente / non publié | Clene Nanomedicine | United States · Healey Center for ALS at Mass General… | 2020-07-30 → 2023-03-07 | Ouvrir |
| NCT04081714 Intermediate Expanded Access Protocol CNMAu8.EAP03 |
CNM-Au8 | SEP | À vérifier | TEMPORARILY_NOT_AVAILABLE | En attente / non publié | Clene Nanomedicine | United States · University of Texas Southwestern, Dal… | Non communiqué | Ouvrir |
| NCT04098406 Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic La… |
CNM-Au8 | SEP | Phase 2 | COMPLETED | En attente / non publié | Clene Nanomedicine | Australia · University of Sydney Brain and Mind Centr… | 2019-12-19 → 2021-07-13 | Ouvrir |
| NCT04725175 Phase I Study Evaluating Safety and Tolerability of Escalating Single a… |
PIPE-307 | SEP | Phase 1 | COMPLETED | En attente / non publié | Contineum Therapeutics | Australia · Linear Clinical Research, Nedlands, Austr… | 2021-02-26 → 2021-09-01 | Ouvrir |
| NCT04941781 PET Study to Determine the Relationship Between Plasma Concentrations a… |
PIPE-307 | SEP | Phase 1 | COMPLETED | En attente / non publié | Contineum Therapeutics | United Kingdom · Hammersmith Medicines Research, Lond… | 2021-09-01 → 2021-11-10 | Ouvrir |
| NCT06746623 Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chr… |
Nonendoscopic Screening for Barre… | SEP | NA | RECRUITING | En attente / non publié | Louis Stokes VA Medical Center | United States · VA Northeast Ohio Healthcare System, … | 2025-04-11 → 2028-12-31 | Ouvrir |
| NCT05367050 Impact of a Behavioral Tele-health Program on the Quality of Recovery f… |
Impact of a Behavioral Tele-healt… | SEP | NA | UNKNOWN | En attente / non publié | Lucid Lane, Inc | United States · Palo Alto Division - VA Palo Alto Hea… | 2021-05-04 → 2023-04 | Ouvrir |
| NCT00860951 P300 Brain Computer Interface Keyboard to Operate Assistive Technology |
Brain Computer Interface Keyboard | Sclérose latérale amyotrophique | Phase 1 | COMPLETED | En attente / non publié | University of Michigan | United States · University of Michigan Direct Brain I… | 2008-09 → 2012-05 | Ouvrir |
| NCT06917924 A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PE… |
A Patient-tailored Genetic/Biomar… | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | A.O.U. Città della Salute e della… | Italy · AOU Citta della Salute e della Scienza di Tor… | 2023-05-20 → 2025-11-20 | Ouvrir |
| NCT07423494 Personalized Antisense Oligonucleotide Therapy for A Single Patient Wit… |
nL-CHCHD-001 | Sclérose latérale amyotrophique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | n-Lorem Foundation | United States · Mayo Clinic, Rochester, United States | 2026-03 → 2027-03 | Ouvrir |
| NCT07298486 Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine … |
Robotic Glove Use | Sclérose latérale amyotrophique | NA | ENROLLING_BY_INVITATION | En attente / non publié | Nova Southeastern University | United States · Nova Southeastern University, David a… | 2026-02-09 → 2026-07-30 | Ouvrir |
| NCT00833820 Repetitive Transcranial Magnetic Stimulation (rTMS) in Amyotrophic Late… |
Real rTMS of the brain | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | Catholic University of the Sacred… | Italy · Institute of neurology Università Cattolica, … | 2007-05 → 2008-12 | Ouvrir |
| NCT05868837 Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) |
Rituximab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | Italy · Policlinico A. Gemelli IRCCS, Roma, Italy | 2022-02-28 → 2025-07-31 | Ouvrir |
| NCT02473965 Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With… |
IGIV-C | Myasthénie | Phase 2 | COMPLETED | En attente / non publié | Grifols Therapeutics LLC | United States, Belgium, Canada, Czechia, Estonia, Fra… | 2015-06 → 2019-02 | Ouvrir |
| NCT07333196 Tongji NADs Cohort |
Tongji NADs Cohort | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital of Tongji Medical College, Hu… | 2026-03-01 → 2037-03-01 | Ouvrir |